FIELD: medicine. SUBSTANCE: method involves introducing 1 ml human embryo tissue suspension together with protein-nuclein extraction of the tissue taken in the amount of 0.01-0.05 mg of mixture dry residue per 1 kg of patient body mass into brain liquor space of the patient and next to it intranasally administering the like dose of the extraction solution 4 times a day 2 drops in every nasal passage during 7 days. EFFECT: enhanced effectiveness of implanted material interaction with brain tissues.
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING STROKE CASES | 2004 |
|
RU2283121C2 |
METHOD TO TREAT DISORDERS OF CENTRAL NERVOUS SYSTEM | 1996 |
|
RU2112526C1 |
AGENT FOR STIMULATION OF CELLS PROLIFERATION, COMPOSITE FOR STIMULATION OF CELLS PROLIFERATION AND METHOD FOR TREATMENT OF WOUNDS, BURNS AND ULCERS OF DIFFERENT ETIOLOGY | 2001 |
|
RU2214256C2 |
METHOD FOR TREATING VERTEBRAL COLUMN INJURY CASES | 2005 |
|
RU2286160C1 |
METHOD FOR TREATMENT OF ORGANIC DAMAGE IN CENTRAL NERVOUS SYSTEM BY ENDOLUMBAL TRANSPLANTATION OF HUMAN FETAL CELLS | 2002 |
|
RU2234930C2 |
METHOD OF TREATMENT OF DEMYELINIZING DISTURBANCES OF CENTRAL NERVOUS SYSTEM | 1998 |
|
RU2136299C1 |
METHOD FOR TREATING TRAUMATIC SPINAL LESIONS | 2000 |
|
RU2195941C2 |
BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF PARKINSONISM | 2004 |
|
RU2259836C1 |
CELLULAR SUSPENSION-BASE DRUG AND METHOD OF TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME (HIV-INFECTION) USING THIS PREPARATION | 1994 |
|
RU2137484C1 |
METHOD FOR TREATING CHILDREN FOR PERINATAL NEUROLOGIC PATHOLOGY | 2001 |
|
RU2228187C2 |
Authors
Dates
1999-04-27—Published
1996-04-30—Filed